• Burden Of Hospitalizations Related To Chronic Hepatitis C In Fran Evolution Between 2009 And 2012

    Nov 1, 2014, 00:00

  • An Assessment Of The Current Literature On Apheresis Use In The Treatment Of Familial Hypercholesterolemia

    Nov 1, 2014, 00:00

  • Impact of Early Microbiologic Culture in the Economic Burden of Care for Patients With Infected Diabetic Foot Ulcers At A Model Of Secondary Level Imss' Hospitals in Mexico

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions

    Nov 1, 2014, 00:00

  • Projection of Long Term Health Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Uncontrolled Type 1 Diabetes In France

    Nov 1, 2014, 00:00

  • Health Technology Assessments In Oncology- Crizotinib Case Study

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Long-Acting Paliperidone in Comparison with Oral Risperidone, Oral Paliperidone and Long-Acting Risperidone in the Maintenance Treatment of Schizophrenia in the Czech Republic

    Nov 1, 2014, 00:00

  • Hospitalizations And Costs In Patients With Implantable Cardioverter Defibrillators- Association Of Long Verse Standard Detection Intervals

    Nov 1, 2014, 00:00

  • Exposure To Potential Drug-Drug Interactions in Teaching Hospital Of South Punjab, Pakistan

    Nov 1, 2014, 00:00

  • Usability Testing of A Novel Pain Medication Diary Administered Electronically

    Nov 1, 2014, 00:00

  • Evaluation of a Multidisciplinary Home-Based Medication Review Program for Elderly Singaporeans

    Nov 1, 2014, 00:00

  • Determinants of Non-Persistence to Antiosteoporotic Drugs by Using Administrative Database

    Nov 1, 2014, 00:00

  • Exploring the Willingness-to-Pay for Innovative Treatments for Immunology and Oncology in China

    Nov 1, 2014, 00:00

  • Patterns and Trends In Opioid Use In Iran From 2007 To 2011

    Nov 1, 2014, 00:00

  • Modelling the Impact of Persistence Improvements with an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients with Relapsing Remitting Multiple Sclerosis (RRMS)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Aflibercept in the Treatment of Macular Oedema Secondary to Central Retinal Vein Occlusion In Sweden

    Nov 1, 2014, 00:00

  • Detection and Evaluation of the Medication Errors in Different Hospitals in Province of the Punjab, Pakistan

    Nov 1, 2014, 00:00

  • What are the Health Care Resource Utilization and Medical Cost of Untreated Patients with Neuroendocrine Tumors in the United States?

    Nov 1, 2014, 00:00

  • Efficacy of Virtual Reality Exposure Therapy in the Management of Symptoms Associated With Post Traumatic Stress Disorder

    Nov 1, 2014, 00:00

  • Quality Of Life Assessments In Korean Patients With Rheumatoid Arthritis (Ra)- An Analysis From The Phase Iii Trial To Evaluate Equivalence Of The Etanercept Biosimilar Hd203 And Enbrel® In Combination With Methotrexate (Mtx) In Patients Wi ...

    Nov 1, 2014, 00:00

  • Economic Burden of Intravenous Iron Products In Public Hospitals of Paris and Impact of Their New Hospital-Restricted Status

    Nov 1, 2014, 00:00

  • Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 96-Week Results of the Rapid ...

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Latanoprost Compared with Dorzolamide/Timolol Fixed Combination for the Treatment of Open-Angle Glaucoma and Ocular Hypertension Patients in Korea

    Nov 1, 2014, 00:00

  • Epidemiology of End Stage Renal Disease Patients on Hemodialysis for Hospital Readmissions

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Education in Brazilian Schools of Pharmacy

    Nov 1, 2014, 00:00

  • The Cost of Active Systemic Lupus Erythematosus in Greece Results From the Lycos Study

    Nov 1, 2014, 00:00

  • A Systematic Literature Review on Risk Factors for Cervical Cancer in Chinese Population

    Nov 1, 2014, 00:00

  • The Socioeconomic Costs of the Undertreatment of Pain

    Nov 1, 2014, 00:00

  • Utility Values Among Myopic Patients in Mainland China

    Nov 1, 2014, 00:00

  • Human Epididymis Protein 4 Test

    Nov 1, 2014, 00:00

  • Budget impact analysis of peritoneal dialysis versus. Conventional in-center hemodialysis in malaysia

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis Of Fidaxomicin Compared To Vancomycin In The Management Of Severe Clostridium Difficile Infection In Poland

    Nov 1, 2014, 00:00

  • Research Presentations Financial Disclosure Statements ISPOR 6th Asia-Pacific Conference Abstracts

    Nov 1, 2014, 00:00

  • Does diabetes have an impact on health-state utility? A study of asians in singapore

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Long-Term Outcomes of Sovaldi (SOFOSBUVIR) for the Treatment of Chronic Hepatitis C Infected (HCV) Patients from a Swedish Societal Perspective

    Nov 1, 2014, 00:00

  • Exploring The Determinants of Endocrinologist Visits In France

    Nov 1, 2014, 00:00

  • Potentially Inappropriate Medicines and Potential Prescribing Omissions in Older People and Their Association With Health Care Utilization- A Retrospective Cohort Study

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Belimumab In the Treatment of Adult Systemic Lupus Erythematosus (Sle) Patients With Positive Biomarkers In Spain

    Nov 1, 2014, 00:00

  • Care Needs for Rheumatoid Arthritis from Patient Perspectives- A Qualitative Study from Singapore General Hospital

    Nov 1, 2014, 00:00

  • Determination of Availability of Antimicrobial Preparations for Treatment of Community-Acquired Pneumonia in Ukraine

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis Comparing Propranolol With Corticosteroids in the Treatment of Proliferating Infantile Hemangioma in Italy

    Nov 1, 2014, 00:00

  • Health Behavior And Medication Adherence

    Nov 1, 2014, 00:00

  • Comparing Access to Drugs Through the CDF and by Nice – The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage

    Nov 1, 2014, 00:00

  • Clotting Factor (Cf) Product Use And Same-Day Risk For Thrombotic Adverse Events (Tes), As Recorded In Large Health Care Database During 2008-2013 Study Period

    Nov 1, 2014, 00:00

  • Methodological Assessment of Matching-Adjusted Indirect Comparisons- Case Study Application To Attention Deficit/Hyperactivity Disorder (Adhd)

    Nov 1, 2014, 00:00

  • Constructing A Comorbidity Index According To Iso-Resource Consumption

    Nov 1, 2014, 00:00

  • Health State Utilities for Pressure Ulcers – A Comparison of Condition-Specific and Generic Measures and Time-Trade-Off (Tto)

    Nov 1, 2014, 00:00

  • The Cost Effectiveness of Group Art Therapy for Patients with Non-Psychotic Mental Health Disorders in England And Wales

    Nov 1, 2014, 00:00

  • The statistical analysis of delayed effects in survival outcomes for immunotherapies. Estimation of time-delay and application of weighted log rank

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Laser Doppler Imaging in Burn Care in The Netherlands; A Randomised Controlled Trial

    Nov 1, 2014, 00:00

  • Health Related Quality of Life in Cancer Patients- Evaluation With A Self-Administered Ipad Application

    Nov 1, 2014, 00:00

  • Approaches Used to Model the Relationship Between Progression-Free Survival (PFS) / Time-To-Progression (TTP) And Overall Survival (OS) Within Health Economic Models of Cancer Therapies

    Nov 1, 2014, 00:00

  • Trends In Prescription Opiate Use Among Patients With Commercial Or Government Sponsored Health Insurance In the Us From 2010-2013

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Paliperidone Palmitate in the Treatment of Schizophrenia- A Meta-Analysis

    Nov 1, 2014, 00:00

  • The Life and Death of the End of Life Treatment Appraisal Criteria in Nice Technology Appraisals?

    Nov 1, 2014, 00:00

  • Impact of Glp-1RA on Heart Rate, Blood Pressure and Hypertension Among Type 2 Diabetes- A Systematic Review and Network Meta-Analysis

    Nov 1, 2014, 00:00

  • A Cost-Utility Analysis of Cervical Cancer Screening and Human Papilloma Virus Vaccination In the Philippines

    Nov 1, 2014, 00:00

  • Which Metric To Choose For Indirect Comparison Of Treatments When Multiple Comparisons Are Feasible- Lubiprostone Verse Prucalopride In Chronic Constipation

    Nov 1, 2014, 00:00

  • The Long-Term Outcomes Of Bariatric Surgery On Patients With Type 2 Diabetes Mellitus- A Systematic Review And Meta-Analyses

    Nov 1, 2014, 00:00

  • Romanian Quick-HTA Development In 2013

    Nov 1, 2014, 00:00

  • Hospitalization Costs For Community-Acquired Pneumonia In Elderly In The Netherlands

    Nov 1, 2014, 00:00

  • Assessing the Effectiveness AND Cost-Effectiveness of Audit and Feedback on Physician's Prescribing Indicators

    Nov 1, 2014, 00:00

  • Trends in Time To Market Access In Europe - Is It Getting Better?

    Nov 1, 2014, 00:00

  • Research on Health Services Need and Utilization of the Rural Elderly Left at Home in Shaanxi Province, China

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Thrombolysis Within 4.5 Hours of Acute Ischemic Stroke in China

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Fulvestrant in the Treatment of Metastatic Breast Cancer in Second-Line Chemotherapy

    Nov 1, 2014, 00:00

  • Choosing Important Health Outcomes For Comparative Effectiveness Research- A Systematic Review

    Nov 1, 2014, 00:00

  • Real World Studies Using Japanese Administrative Databases- Chronic Hepatitis C Treatment Pattern And Resource Use

    Nov 1, 2014, 00:00

  • Drug Utilisation in Cardiovascular Diseases Management in Slovakia- 8 Years Overview

    Nov 1, 2014, 00:00

  • Resource Use and Health Care Costs of Cervical Lesions and Cervical Cancer in Slovakia

    Nov 1, 2014, 00:00

  • Determination Of The Annual Health Insurance Cost Of Outpatient Care Physiotherapy Services For Low Back Pain

    Nov 1, 2014, 00:00

  • Reimbursement Decisions for Pharmaceuticals in Sweden- the Impact of Cost-Effectiveness and Disease Severity

    Nov 1, 2014, 00:00

  • Endpoints in Pain- the Suitability for Health Economic Evaluation of Endpoint Designs in Chronic Pain Studies

    Nov 1, 2014, 00:00

  • Potential Efficency and Cost Savings To the English Nhs By A Laparoscopic Aproach To Total Abdominal Hysterectomy

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Hydralazine and Magnesium Valproate LP Associated With Treatment for Adult Patients with Metastatic Recurrent or Persistent Cervical Cancer in Mexico

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Wider Adoption Of Biphasic Insulin Aspart (Biasp) In The Treatment Of Type 2 Diabetes Mellitus (T2dm)- A Perspective Of Patients Treated By Public Providers In Singapore

    Nov 1, 2014, 00:00

  • Responsiveness and Minimal Clinically Important Difference of A Specific Health Related Quality of Life (Hrqol) Questionnaire for Home Enteral Nutrition (Hen) Patients- Nutriqol® Questionnaire

    Nov 1, 2014, 00:00

  • Cost of Non Small Cell Lung Cancer by Vietnamese and European Treatment Standards in Vietnam

    Nov 1, 2014, 00:00

  • The Role Of Prior Breast Cancer Diagnosis In Articulating Expectations For Reconstructed Breast Appearance

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada

    Nov 1, 2014, 00:00

  • Regulatory Approval To Patient Access, An Evaluation of Eu5 And Us National Timing Differences- An Update

    Nov 1, 2014, 00:00

  • The Pension Costs of Musculoskeletal Diseases. Estimation of the Economic Burden Borne by the Italian Social Security System

    Nov 1, 2014, 00:00

  • Resource use and Costs for Managing HCV Genotype 1 Patients in Colombia from the Payers Perspective

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Ipilimumab in Previously Untreated Patients With Unresectable Malignant Melanoma in Scotland

    Nov 1, 2014, 00:00

  • Cost Related to the Waiting List of Patients With Vertebral Malformation

    Nov 1, 2014, 00:00

  • Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv)

    Nov 1, 2014, 00:00

  • Likely Impact of Net Price Referencing on European Markets

    Nov 1, 2014, 00:00

  • Is a Home Based Video Teleconcultation Setup Cost Effective For Lowering Hba1c For Patients With Type-2 Diabetes Over A Six-Month Period?

    Nov 1, 2014, 00:00

  • Inhaled Anticholinergics and Risk for Acute Urinary Retention- A Case-Crossover and Case-Time-Control Study

    Nov 1, 2014, 00:00

  • Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up- Prefer In Af Registry

    Nov 1, 2014, 00:00

  • Metformin in Combination With Dipeptidyl Peptidase-4 Inhibitors or Sulfonylureas in The Treatment of Type 2 Diabetes- Clinical And Economic Impact

    Nov 1, 2014, 00:00

  • Duration of Treatment in Pulmonary Tuberculosis- are International Guidelines on the Management of Tuberculosis Missing Something?

    Nov 1, 2014, 00:00

  • labour induction with prostaglandins- what works best? A systematic review, network meta-analysis and cost-effectiveness analysis

    Nov 1, 2014, 00:00

  • A Comparison of Asian and Global Pharmaceutical Prices Using an EKS Method

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of High-Dose Levofloxacin Therapy of Patients With Community-Acquired Pneumonia

    Nov 1, 2014, 00:00

  • The Opportunity of Treating Type Ii Diabetes With Dpp4i- An Economic Evaluation Verse Conventional Treatment in the Italian Setting

    Nov 1, 2014, 00:00

  • The Health Service and Economic Impact of Glucagon Rescue Administration During Severe Hypoglycemic Events

    Nov 1, 2014, 00:00

  • Does Giving Carers a Break Improve their Wellbeing? Results from an Evaluation using the EQ-5D-5L

    Nov 1, 2014, 00:00

  • Kazakhstan Verse Uzbekistan- A Review of the Drug Provision Systems

    Nov 1, 2014, 00:00

  • Measuring the Trend of Use of Targeted Therapy and Economic Evaluation of Gefitinib for Advanced Non-Small Cell Lung Cancer (Nsclc) in Singapore

    Nov 1, 2014, 00:00

  • Impact of Allergen Immunotherapy on Symptom-Free Days and Health Care Costs in Patients With Grass Pollen-Induced Allergic Rhinitis in Germany

    Nov 1, 2014, 00:00

  • Can Gastric Cancer Patients be Successfully Recruited for Clinical Phase III/IV and Health Outcome Studies Using Managed Physician Panels?

    Nov 1, 2014, 00:00

  • Impact of Patient Programs On Adherence In Inflammation and Immunology- A Global Systematic Review and Meta-Analysis of Published Evidence

    Nov 1, 2014, 00:00

  • Indirect Comparison of Exacerbation Frequency Between Aclidinium and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease

    Nov 1, 2014, 00:00

  • Prescribing Pattern of Antibiotics In Neonates in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • A Systematic Literature Review to Identify Trials in First-Line Ras Wild-Type (WT) Metastatic Colorectal Cancer (MCRC) Patients

    Nov 1, 2014, 00:00

  • Assessing the Relationship Between Treatment Effect and Baseline Risk in Network Meta-Analsysis of Moderate to Severe Chornic Plaque Psoriasis Trials

    Nov 1, 2014, 00:00

  • Adaptive Video Games can Assess and Enhance Cognitive Health

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Evaluation of Brentuximab Vedotin for Refractory/Relapsed Hodgkin Lymphoma- A Comparative Analysis of the Results of Mexico and Venezuela

    Nov 1, 2014, 00:00

  • A Dutch Administrative Database in Support of Economic Evaluations- A Feasibility Study

    Nov 1, 2014, 00:00

  • Health Implications of the MTM Eligibility Criteria In The Affordable Care Act Across Racial And Ethnic Groups

    Nov 1, 2014, 00:00

  • Brio- A European Prospective Observational Study to Assess the Burden of Disease and Treatment in Metastatic Breast Cancer (Mbc) Patients Treated with Oral Vinorelbine (Nvboral) or Intravenous Vinorelbine (Ivvino)

    Nov 1, 2014, 00:00

  • Activation of Endogenous Anti-Inflammatory Mediator Cyclic Amp Confers Protection in Murine Acute Pyelonephritis Induced by Uropathogenic E Coli

    Nov 1, 2014, 00:00

  • Sources of Information and Pharmacists' Knowledge Regarding Rare Diseases and Orphan Drugs- Cross-Sectional Study In Serbia

    Nov 1, 2014, 00:00

  • Role of Corticosteroids Use in Ards- Comparison of Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Importance Of Remission In Patients With Major Depressive Disorder In Korea For Improving Health-Related Quality Of Life And Economic Burden

    Nov 1, 2014, 00:00

  • Generic Penetration Within Top-10 Genericized Molecules – Greece Versus Major European Countries

    Nov 1, 2014, 00:00

  • Assessing the Translatability of the Term “Frustrated”

    Nov 1, 2014, 00:00

  • A Cost Effectiveness Analysis of Everolimus Plus Exemestane Compared to Chemotherapy Agents for the Treatment of ER+ HER2- Metastastic Breast Cancer in the United Kingdom

    Nov 1, 2014, 00:00

  • HBA1C Control Predictive Validity of Four Self-Reported Measures of Antidiabetes Medication Adherence

    Nov 1, 2014, 00:00

  • Multi-Criteria Decision Analysis (MCDA)- Testing a Proposed Mcda Model for Orphan Drugs

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors- Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Smoking Cessation Treatment Patterns and Characteristics of Patients with Copd Who are Attempting to Quit in Urban China

    Nov 1, 2014, 00:00

  • Clinical Characteristics Among Hypertension Patients with Diabetes in Shanghai, China

    Nov 1, 2014, 00:00

  • Proposed Checklist for Non-Statisticians To Assess the Quality of A Network Meta-Analysis in the Context of A Nice Submission

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in France

    Nov 1, 2014, 00:00

  • Results of A Decubitus Prevention and Wound Care Project

    Nov 1, 2014, 00:00

  • The Analysis of Dental Care in Ukraine at the Regional Level

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation Study On Preoperative Treatment Of Acromegaly With Somatostatin Analogues In Shanghai

    Nov 1, 2014, 00:00

  • Awareness and Interest in the United States Health Insurance Marketplace

    Nov 1, 2014, 00:00

  • Self Reported Health Care Resource Use and Indirect Economic Burden of Opioid Induced Constipation (Oic)

    Nov 1, 2014, 00:00

  • Cost Effectiveness 0f Propofol Verses Thiopental in Icu Wards

    Nov 1, 2014, 00:00

  • Daily Dose and Costs Associated With Maintenance Therapy of Topical Testosterone Agents Among Hypogonadal Men

    Nov 1, 2014, 00:00

  • Instructions for Authors

    Nov 1, 2014, 00:00

  • The Effectiveness Of Carotid Artery Stenting Compared With Endarterectomy In Symptomatic Patients With Carotid Stenosis In Korean Multi-Center Setting

    Nov 1, 2014, 00:00

  • The Use of Real World Data in the Decision-Making Process- An Example Using Blood Glucose Test Strip Use In Patients With Type 2 Diabetes In Ireland

    Nov 1, 2014, 00:00

  • What Drives Unemployment of HIV-Infected Patients in Germany?

    Nov 1, 2014, 00:00

  • The Valuation of EQ-5D-5L Health States in Korea

    Nov 1, 2014, 00:00

  • Assessment of Validity of An Indicator Module In Identification of adverse Drug Events in Patients of Medicine Department

    Nov 1, 2014, 00:00

  • Impact of Non-Consented Switch and Subsequent Switch in Asthma Medication- Qualitative Study of Patient Perspective in the UK

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in China

    Nov 1, 2014, 00:00

  • Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012

    Nov 1, 2014, 00:00

  • Patient Adherence Among Adolescents With Arterial Hypertension

    Nov 1, 2014, 00:00

  • How The Implementation Of Drug Zero Markup Policy Will Affect Health Care Expenditure In Hospitals- Observation And Prediction Based On Zhejiang Model

    Nov 1, 2014, 00:00

  • Reasons for Treatment Discontinuation of Biologics – Development and Validation of A Questionnaire

    Nov 1, 2014, 00:00

  • Health Insurance Cost of Anxiety in Hungary- A Cost of Illness Study

    Nov 1, 2014, 00:00

  • Xpert Mtb/Rif Assay for Rapid Diagnosis in Patients with Suspected Tuberculosis in Hong Kong - a Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Economic Burden of Disease in France In 2012- A Top-Down Allocation of Health Care Expenditure by Disease Based on the French Health insurance Database (SNIIRAM)

    Nov 1, 2014, 00:00

  • The Long-Term Value of Glatiramer Acetate for the Treatment of Relapsing Remitting Multiple Sclerosis in the Netherlands

    Nov 1, 2014, 00:00

  • The Evolution of International Reference Pricing- An Analysis of 39 Countries

    Nov 1, 2014, 00:00

  • Loyalty To A Pharmacy Is Associated With A Better Quality Of Antidiabetes Drug Use

    Nov 1, 2014, 00:00

  • Increased Bone Mineral Density (Bmd) In Postmenopausal Women With Osteoporosis (Op) Receiving Two Denosumab Injections In Routine Clinical Practice In Bulgaria

    Nov 1, 2014, 00:00

  • Level of Testing for Potential Medication-Related Co-Morbidities for Patients Taking Antipsychotics

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Ldl-P-Guided Statin Therapy

    Nov 1, 2014, 00:00

  • Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer

    Nov 1, 2014, 00:00

  • The Economic Burden and their Predictors in Preschool Children with Dental Caries in Urban Beijing

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin In The Treatment And Secondary Prevention Of Acute Venous Thromboembolism In The Uk

    Nov 1, 2014, 00:00

  • Hydroxyethyl Starch And Hospitalized Mortality In Icu Patients With Diabetes- Database Study From A Chinese Tertiary Hospital

    Nov 1, 2014, 00:00

  • From Clinically Relevant Outcome Measures To Quality of Life in Epilepsy

    Nov 1, 2014, 00:00

  • Off-Label Use of Anticancer Drugs In South Korea

    Nov 1, 2014, 00:00

  • Assessment of Health States and Erectile Dysfunction-Associated Quality of Life Among Adult Males and Females With Male Partners in Germany, the United Kingdom and the United States

    Nov 1, 2014, 00:00

  • Characterizing Work Productivity Loss In Incident Rheumatoid Arthritis In Sweden

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Sofosbuvir For The Treatment Of Hepatitis C In The Veneto Region, Italy

    Nov 1, 2014, 00:00

  • Price Control Of Out-Patient Cancer Drugs In Bulgaria, 2010-2011- Reference Based Pricing And Public Tenders Verse Reference Based Pricing Only

    Nov 1, 2014, 00:00

  • An Analysis of the Drivers of Pricing Premiums Granted to Innovative Products in Japan

    Nov 1, 2014, 00:00

  • Key Cost Drivers Of Type 2 Diabetes Mellitus- an International Literature Review

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Percent Free Psa for Prostate Cancer Detection in Chinese Men with a Total Psa of 4.0-10.0 Ng/Ml

    Nov 1, 2014, 00:00

  • A Novel Broadly Applicable Risk Score for Predicting Mortality of Patients with Circulatory System Diseases within Hospitalization Duration

    Nov 1, 2014, 00:00

  • A Gender Medicine Post-Hoc Analysis- Background and Methods of the Metagem Project

    Nov 1, 2014, 00:00

  • Health State Utility Valuation in Radio-Iodine Refractory Differentiated Thyroid Cancer (RR-DTC)

    Nov 1, 2014, 00:00

  • Trends in Physical and Occupational Therapy Utilziation in the Us And Western Europe

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Dolutegravir for HIV Patients in Slovenia

    Nov 1, 2014, 00:00

  • Cost Minimization Analysis of Activated Prothrombin Complex Concentrate (Apcc) Compared To Recombinant Factor Viia (Rfviia) for Hemophilia Patients With Inhibitors

    Nov 1, 2014, 00:00

  • Psychometric Validation of the Newly Developed Phenylketonuria– Quality of Life (Pku-Qol) Questionnaires Assessing the Impact of Phenylketonuria and Its Treatment On Patients' Quality of Life

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of the Lidocaine 5% Medicated Plaster Verse Pregabalin and Amitriptyline for the Treatment of Post-Herpetic Neuralgia In the Netherlands

    Nov 1, 2014, 00:00

  • Incidence of Drug Related Problem Admissions Emergency Department Visits in a Secondary Care Hospital in South India

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-To-Severe Active Rheumatoid Arthritis In Greece

    Nov 1, 2014, 00:00

  • Evaluating The Effect Of Immunotherapy In Advanced Non-Small- Cell Lung Cancer Patients Using Two Components Mixture Model

    Nov 1, 2014, 00:00

  • How Successful Have Pediatric Investigation Plans Been In Stimulating Research For Pediatric Cancers?

    Nov 1, 2014, 00:00

  • Uses of Electronic Patient Information Systems and National Registers – Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland

    Nov 1, 2014, 00:00

  • The Performance- Volume Limit Decreased the DRG Based Acute Care Hospital Financing in hungary

    Nov 1, 2014, 00:00

  • Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis In Portugal

    Nov 1, 2014, 00:00

  • Sharing of Information Across Studies to Inform Choice of Functional Form When Conducting Parametric Survival Analysis

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Five New Antidepression Drugs A Network Meta Analysis

    Nov 1, 2014, 00:00

  • Evidence-Based Market Access Value Resour Navigating The Hurdles for A Biologic Obtaining A License In A Second Indication in Key European Countries

    Nov 1, 2014, 00:00

  • Relative Efficacy And Safety of Ustekinumab Compared to Anti-TNF-Alfa Therapies in Patients With Active Psoriatic Arthritis

    Nov 1, 2014, 00:00

  • Assessing the Effectiveness of Counter Matching for Improving the Efficiency of the Nested Case-Control Design in Observational Studies

    Nov 1, 2014, 00:00

  • Health Economic Model On the Costs and Effects of Rotavirus Vaccination in Romania

    Nov 1, 2014, 00:00

  • Examining The Role Of Insulin Pen Devices In Acute Care Settings- A Review And Analysis of Health Resource Utilization

    Nov 1, 2014, 00:00

  • Modeled Outcomes and Overall Costs of the 13-Valent Pneumococcal Conjugate Vaccine in the Tunisian National Vaccination Program

    Nov 1, 2014, 00:00

  • The Cost Of Increasing Physical Activity And Decreasing Body Mass Index For Mid-Life African Women

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Para-Aortic Lymphadenectomy Before Chemoradiotherapy in Locally Advanced Cervical Cancer

    Nov 1, 2014, 00:00

  • The Association Between The Nature And Timing Of Dental Visits And C-Reactive Protein Levels

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Mycophelonate Sodium On Patients With Renal Transplant At The Public Mexican Health Care System

    Nov 1, 2014, 00:00

  • Economic Burden of Burn Injuries in the Netherlands

    Nov 1, 2014, 00:00

  • Health-Related Quality of Life Among Tuberculosis Patients in Pakistan- A Cross Sectional Study Using WHOQOL-BREF

    Nov 1, 2014, 00:00

  • Acute Respiratory Distress Syndrome- Treatment Pattern and Outcome Analysis

    Nov 1, 2014, 00:00

  • Systematic Review and Mixed Treatment Comparison of Lithium or an Atypical Anti-Psychotic (AAP) used to Augment a Selective Serotonin Reuptake Inhibitor (SSRI) in Treatment Resistant Depression (TRD)

    Nov 1, 2014, 00:00

  • Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Human Papillomavirus Vaccination Programmes Parallel to Current Routine Vaccination of Young Teenage Girls

    Nov 1, 2014, 00:00

  • A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Combined With A Quantitative Analysis of the Multi-Stakeholder Benefit ...

    Nov 1, 2014, 00:00

  • Burden of Drug Waste in Oncology- Optimization of Resource Use

    Nov 1, 2014, 00:00

  • Are “Lively” and “Full of Pep” Similar Or Different Concepts? Challenges in Translating These Terms in Seven Languages

    Nov 1, 2014, 00:00

  • Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Umeclidinium Bromide Compared to Tiotropium Bromide for Symptomatic Patients with COPD in the UK

    Nov 1, 2014, 00:00

  • New Observer-Reported Outcomes To Measure Treatment Satisfaction, Compliance, Palatability, and Gi Symptoms for Patients Needing Iron-Chelation Therapy

    Nov 1, 2014, 00:00

  • Assessment of Lung Cancer Treatment by Disease Phase Using National Cancer Registry Data Linked with Treatment Pathway cost Data in Austria

    Nov 1, 2014, 00:00

  • Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and Mabcute

    Nov 1, 2014, 00:00

  • Economic Impact of Genetic Diagnostic Test For Breast Cancer - Health Technology Assessment in Slovak Health Care Environment

    Nov 1, 2014, 00:00

  • The Cost of Costing Treatments Incorrectly- Errors in the Application of Drug Prices in Economic Models Due to Differing Patient Weights

    Nov 1, 2014, 00:00

  • Nurses' Perception Towards the Benefits of Pharmaceutical Care Services in Tertiary Health Care Settings Pakistan- A Qualitative Insight

    Nov 1, 2014, 00:00

  • Systematic Review of Societal Cost of Illness Evidence in Patients With Ankylosing Spondylitis

    Nov 1, 2014, 00:00

  • Pre-Symptomatic Genetic Testing In Familial Amyloid Polyneuropathy- The Reproductive Options

    Nov 1, 2014, 00:00

  • Real-World Cost-Utility Evaluation of Multiple Myeloma Treatments In Stem Cell Transplanted Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Coffee Consumption for Prevention of All-Cause Mortality in Germany

    Nov 1, 2014, 00:00

  • Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of 13-Valent Pneumococcal Vaccine in Adult Population with Comorbidities or Immunocompromised from the Public Payer Perspective In Brazil

    Nov 1, 2014, 00:00

  • Burden of Varicella in Asia-Pacific Countries- A Systematic Review and Critical Analysis

    Nov 1, 2014, 00:00

  • Epidemiology and Costs of Varicella and Herpes Zoster in Germany

    Nov 1, 2014, 00:00

  • Creating Patient Profile in Individual Simulations- A Comparison of Approaches

    Nov 1, 2014, 00:00

  • Health and economic impact of combination therapy vs. Monotherapy for treatment of benign prostatic hyperplasia in hong kong

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Dapagliflozin In Combination With Insulin for the Treatment of Type 2 Diabetes Mellitus (T2dm) In Spain

    Nov 1, 2014, 00:00

  • An Analysis of the Key Value Drivers for HTA Assessments In Taiwan

    Nov 1, 2014, 00:00

  • Evaluation of Adverse Drug Reaction (ADR) Monitoring and Reporting System in China

    Nov 1, 2014, 00:00

  • Co-Administration of Turmeric Potentiates Preventive Effect of Black Seeds in Metabolic Syndrome

    Nov 1, 2014, 00:00

  • The Effectiveness and Safety of Febuxostat - An Experience in Medical Center in Taiwan

    Nov 1, 2014, 00:00

  • The Value of Diagnostic Tests for Alzheimer's Disease- Discrete-Choice Experiment and Contingent-Valuation

    Nov 1, 2014, 00:00

  • Identification of Dry Powder Inhaler Attributes, and their Relative Importance to Asthma and Chronic Obstructive Pulmonary Disease Patients, to Inform a Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • Effect of Oral Nutritional Supplements On Hospital Outcomes in Patients Aged 65+ With Congestive Heart Failure

    Nov 1, 2014, 00:00

  • Cost Minimization Analysis Of Clinical Option Scenarios For Metformin And Acarbose In Treatment Of Type 2 Diabetes- Based On Direct And Indirect Treatment Comparison Results

    Nov 1, 2014, 00:00

  • Comparing the Use of Patient-Level Data to An Average Patient Profile Within a Type 2 Diabetes Simulation Model

    Nov 1, 2014, 00:00

  • Cost–Effectiveness of Clopidogrel-Aspirin Versus Aspirin Alone for Acute Tia and Minor Stroke

    Nov 1, 2014, 00:00

  • Systemic Treatment of Metachronous Metastases After Curative Treatment of Breast Cancer

    Nov 1, 2014, 00:00

  • Pharmaceutical Market Access in Emerging Markets Through Innovative Patient Access Schemes

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Everolimus Plus Exemestane Versus Gemcitabine Plus Paclitaxel and Capecitabine Plus Docetaxel in Metastatic Breast Cancer Patients in Egypt

    Nov 1, 2014, 00:00

  • The Reimbursement of Expensive Drugs In Hospitals in Western European Countries

    Nov 1, 2014, 00:00

  • A Review of The Utility Values Used in Published Cost-Effectiveness Analyses of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy in Patients With Diabetic Nephropathy

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania

    Nov 1, 2014, 00:00

  • Describing the Health Status of Schizophrenia Caregivers in the 5E.U

    Nov 1, 2014, 00:00

  • Non-Proliferative Diabetic Retinopathy- is It Cost-Effective to Treat Early?

    Nov 1, 2014, 00:00

  • Budget Impact Model of Ceplene® As Maintenance Therapy in Adult Patients with Acute Myeloid Leukemia in First Remission

    Nov 1, 2014, 00:00

  • Market Analysis in Regard to Biologically Active Supplements And Medicines in Armenia

    Nov 1, 2014, 00:00

  • Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)

    Nov 1, 2014, 00:00

  • Comparative Efficacy And Tolerability Of Solifenacin 5mg Versus Oral Antimuscarinic Agents In Overactive Bladder (Oab)- A Systematic Literature Review (Slr) And Mixed Treatment Comparison (Mtc)

    Nov 1, 2014, 00:00

  • Cost of Treating Acute Promyelocytic Leukemia (APL) Patients in Italy

    Nov 1, 2014, 00:00

  • An Analysis of the Health Technology Assessment Recommendation and Guidance on Use of Eq-5d-5l in Cost-Effectiveness Modeling

    Nov 1, 2014, 00:00

  • Comparative Efficacy and Safety of Empagliflozin with Other Oral Antidiabetic Drugs for the Second Line Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis of A Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Italy

    Nov 1, 2014, 00:00

  • Cost of Illness Analysis of Duchenne Muscular Dystrophy In Italy

    Nov 1, 2014, 00:00

  • Investment Aspects of Generic Drug Policies in Countries With Severe Resource Constraints

    Nov 1, 2014, 00:00

  • Systematic Literature Review and Mixed Treatment Comparison of Gxr Versus other Treatments in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

    Nov 1, 2014, 00:00

  • Treatment Effect Heterogeneity in Clinical Trials- An Evaluation of 13 Large Clinical Trials Using Individual Patient Data

    Nov 1, 2014, 00:00

  • An Ecological Analysis on National Trends and Correlation Between Public Funding for Pneumococcal Vaccination and Pneumonia Disease Burden in the Japanese Elderly Population, 2005-2012

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Eltrombopag As Support Treatment In Chronic Hcv Infected Patients With Thrombocytopenia To Enable Interferon-Based Regimens

    Nov 1, 2014, 00:00

  • Treatments for EGFR Mutation-Positive (M+) NSCLC Patients – A Network Meta-Analysis (NMA) by Mutation Type

    Nov 1, 2014, 00:00

  • The Econimic Cost of Rheumatoid Arthritis in Taiwan

    Nov 1, 2014, 00:00

  • Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy

    Nov 1, 2014, 00:00

  • Mastectomy Due to Breast Cancer in Brazil- Geographic Distribution and Costs from the Public Health Care Perspective

    Nov 1, 2014, 00:00

  • Challenges In Recruiting Patients For The Linguistic Validation Of Pro Instruments Developed For Rare Diseases- A Case Study With Alagille Syndrome

    Nov 1, 2014, 00:00

  • A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The Taiwan

    Nov 1, 2014, 00:00

  • The Future of Education In HTA and Health Economics

    Nov 1, 2014, 00:00

  • Modelling Survival in the Presence of Different Mechanisms of Action- Ipilimumab and Vemurafenib in Advanced Melanoma

    Nov 1, 2014, 00:00

  • Systematic Overview On Value-Of Information Analyses In Cancer Research

    Nov 1, 2014, 00:00

  • Home Pharmacies- An Insight In Self-Medication Practice

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Four Chinese Patent Medicine in the Treatment of Angina Pectoris in China

    Nov 1, 2014, 00:00

  • A Review Of Patient Reported Outcomes (Pros) In Psoriasis According To The Food And Drug Administration (Fda) Pro Guidance Criteria

    Nov 1, 2014, 00:00

  • Assessment of KAP Among Hospital Pharmacists

    Nov 1, 2014, 00:00

  • Primary Treatments for Intermediate-Risk Prostate Cancer- a Cost-Effectiveness and Value-of-Information Analysis

    Nov 1, 2014, 00:00

  • Effect of Health Education Program on Knowledge, Attitude, Practice and Health Related Quality of Life in Hepatitis-B Patients

    Nov 1, 2014, 00:00

  • Quality Of Life – A Rarely Acknowledged Key Category Within The Amnog Process in Germany

    Nov 1, 2014, 00:00

  • Retrospective Analysis of the Economic Burden of Long-Term Care Facility Residents Diagnosed With Alzheimer's Disease in the United States

    Nov 1, 2014, 00:00

  • Task-Based Versus Case-Based Analysis of Time Outcomes in Multi-Country Time and Motion (TM) Studies- Methodological Considerations and Application

    Nov 1, 2014, 00:00

  • The Association of Hosptial Type and Stroke Centre With Mortality, Length of Stay and Hospital Cost of Ischemic Stroke Patients in Alberta

    Nov 1, 2014, 00:00

  • Studies On Clinical Effectiveness Of Combined Classical Ayurvedic Formulations In Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • The Pharmacoeconomics Review of 7-Valent Pneumococcal Conjugate Vaccination in Asian-Pacific Region

    Nov 1, 2014, 00:00

  • Health Economic Evaluation Comparing Iv Iron Ferric Carboxymaltose, Iron Sucrose and Blood Transfusion For Treatment of Patients with Iron Deficiency Anemia (Ida) in Singapore

    Nov 1, 2014, 00:00

  • Third Party Participation in Early Benefit Assessment of Cancer Drugs in Germany

    Nov 1, 2014, 00:00

  • Fda Cdx Category Medication Use During Pregnancy in the United States

    Nov 1, 2014, 00:00

  • Prescribing Pattern and Cost Analysis on (Dmard's) Disease Modifying Anti Rheumatoid Drugs in Rheumatoid Arthritis Patients of a Tertiary Care Teaching Hospital in South India – a Cross Sectional Study

    Nov 1, 2014, 00:00

  • Real-World Data on the Epidemiology and Treatment of HR +, HER2-Advanced Breast Cancer in Postmenopausal Patients in Different Regions of Russia for Forming Markov Models of Managment of Patients

    Nov 1, 2014, 00:00

  • A Tutorial on Dimensionality Reduction in Large Claims Data Sets

    Nov 1, 2014, 00:00

  • Ophthalmology- Therapy Trends in Europe Based on Clinical Trial Registry Data

    Nov 1, 2014, 00:00

  • Epidemiological and Financial Burden of Preterm Labor Hospitalizations – An Analysis of German Claims Data

    Nov 1, 2014, 00:00

  • Encepp-HTA Working Group Survey on Capacity To Conduct Research in Support Of Health Technology Assessment

    Nov 1, 2014, 00:00

  • Disease Burden of Multiple Myeloma in China

    Nov 1, 2014, 00:00

  • The "Venous Age"- A New Tool To Sensitize Patients To Their Venous Disease

    Nov 1, 2014, 00:00

  • Direct Costs Of Diabetes Mellitus In Poland

    Nov 1, 2014, 00:00

  • Development of A Web-Based Tool To Elicit the Opinion of Regionally Dispersed Health Care Professionals Responsible for Medical Device Vigilance

    Nov 1, 2014, 00:00

  • An Evaluation of the Performance of Eq-5d- A Review of Reviews of Psychometric Properties

    Nov 1, 2014, 00:00

  • Rapid Relative Effectiveness Assessment of Pharmaceuticals- Transferability and Completeness of Information Derived From Global Value Dossiers To Complete A Eunethta Submission

    Nov 1, 2014, 00:00

  • Buget Impact Analysis of Rituximab for Chronic Lymphocytic Leukemic- The Case of Brazilian Public Health

    Nov 1, 2014, 00:00

  • Pharmacological Basis for the Medicinal use of Almonds in Cardiovascular Disorders

    Nov 1, 2014, 00:00

  • Use of Medication Reminders in Patients With Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Calcium Supplement in Reducing Preeclampsia-Related Maternal Mortality

    Nov 1, 2014, 00:00

  • Economic Evaluation of the Use of Gefitinib for the Treatment of Locally Advanced or Metastatic NSCLC

    Nov 1, 2014, 00:00

  • Treatment Patterns Among Heart Failure Patients Within 30 Days Post Diagnosis- Results From A Us Claims Database Analysis

    Nov 1, 2014, 00:00

  • Multicriteria Decision Analysis (MCDA) In HTA – Pilot Study in the Czech Republic

    Nov 1, 2014, 00:00

  • Mobile Phone Use in Patient Reported Outcomes– An Updated Literature Search

    Nov 1, 2014, 00:00

  • The Cost Effectiveness Analysis Of The Oral Anti-Viral Treatments Alternatives For The Chronic Hepatitis B In Turkey

    Nov 1, 2014, 00:00

  • Tecepoc II Study. How to Improve the Inhalation Techniques in Patient with Copd. The Influence of Preferences

    Nov 1, 2014, 00:00

  • Health Care Databases Applied to Antidepressants Use in Asia-Pacific

    Nov 1, 2014, 00:00

  • Cost-Minimization and Budget-Impact Analysis of Fixed-Dose Combination Inhalers in Treatment of Copd in Slovenia

    Nov 1, 2014, 00:00

  • Using Hormonal Contraception Reduce Unintended Pregnancy in China

    Nov 1, 2014, 00:00

  • Layering Interventions for Type-2 Diabetes Prevention Using The Sphr Diabetes Model

    Nov 1, 2014, 00:00

  • The Study of Satisfaction and Reasons for Acupuncture Therapy at Sirindhorn National Medical Rehabilitation Centre

    Nov 1, 2014, 00:00

  • Comparison Of Iqwig and G-BA Benefit Ratings in Oncology

    Nov 1, 2014, 00:00

  • Impact of Biologics Use on Depression and Anxiety Frequency and Health Care Resource Utilization In Psoriasis- An Analysis Using the Quebec Provincial Drug Reimbursement Program Database

    Nov 1, 2014, 00:00

  • Health Utility Of Acute Coronary Syndrome Patients From An Asian Population

    Nov 1, 2014, 00:00

  • Prevalence and Associated Complication of Acute Kidney Injury Among Dengue Patients

    Nov 1, 2014, 00:00

  • Health Related Quality of Life and Medication use Among Young College Students During Menstrual Cycle

    Nov 1, 2014, 00:00

  • Estimation of Economic Losses Resulting from Diseases Associated with Smoking in Mexican Insured and Uninsured Population

    Nov 1, 2014, 00:00

  • Construct a Cpoe Decision Supporting and Monitoring System to Decrease Pims Used in Hospitalized Elderly Patients

    Nov 1, 2014, 00:00

  • The Expanding Value Footprint of Oncology Treatments

    Nov 1, 2014, 00:00

  • Analysis of Volume and Structure of Oral Antidiabetic Drugs Consumption in Ukraine

    Nov 1, 2014, 00:00

  • Association Between Baseline Socio-Demographic and Clinical Characteristics and Total Annual Cost of Patients Subjected to CRMDS Implantation

    Nov 1, 2014, 00:00

  • Cost-Consequence Analysis of an Aprepitant Regimen Versus a Standard Antiemetic Regimen for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting in Italy

    Nov 1, 2014, 00:00

  • Effect of Vaccination Age on Cost-Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer in China

    Nov 1, 2014, 00:00

  • Estimation of the Cost of Childhood Asthma in Turkey

    Nov 1, 2014, 00:00

  • Coverage or Efficacy- Which Factor is the Most Influential for Reducing Varicella with Routine Childhood Vaccination in Italy?

    Nov 1, 2014, 00:00

  • Methods To Elicit Patient Preferences- A Case Study In Metastatic Breast Cancer

    Nov 1, 2014, 00:00

  • Evaluation of Cost Effectiveness of OM-85 in China

    Nov 1, 2014, 00:00

  • Sequential Combination of Chemotherapy With Egfr-Tki As The First-Line Treatment for Unselected Patients With Advanced Non-Small Cell Lung Cancer- Systematic Review of Randomized Controlled Trials

    Nov 1, 2014, 00:00

  • Health Literacy and Health Care Utilization Among Adults with Osteoporosis

    Nov 1, 2014, 00:00

  • Budgetary Implications of Introducing Fluticasone Furoate/Vilanterol for Asthma in the UK

    Nov 1, 2014, 00:00

  • Economic Impact of Levalbuterol Versus Albuterol in Low-Income Population

    Nov 1, 2014, 00:00

  • An Observational Cohort Study of Diabetes-Associated Secondary Health Care Utilisation in Patients With Type 2 Diabetes Prescribed Dual Combination Therapy With Oral Anti-Hyperglycaemic Agents in the UK

    Nov 1, 2014, 00:00

  • A De-Novo Economic Model to Assess Clinical and Economic Consequences of Bronchiectasis

    Nov 1, 2014, 00:00

  • The Impact of Mutliple Sclerosis Severity on Quality of Life, Stress, Depression and Social Support Needs

    Nov 1, 2014, 00:00

  • Understanding Trends In Ophthalmologist Patient Selection And Care Based On Patterns Of Billing

    Nov 1, 2014, 00:00

  • Construct Validity of SF-6D Health State Utility Values in an Employed Population

    Nov 1, 2014, 00:00

  • Association of Hypoglycemia With Different Oral Antidiabetic Treatments and Its Impact on Quality of Life and Disease Control In Patients With Type 2 Diabetes Mellitus (The Hypo Study)

    Nov 1, 2014, 00:00

  • Comparison on the Concept of Market Access of China and Western Countries

    Nov 1, 2014, 00:00

  • Calibration And Statistical Modeling To Inform A Micro-Simulation Model For Early HTA

    Nov 1, 2014, 00:00

  • Use Of Factor Analysis To Obtain Independent Health Performance Indicators

    Nov 1, 2014, 00:00

  • Cost-Minimisation Analysis of Saxagliptin Compared to Sitagliptin And Linagliptin As Triple Therapy In Combination With Metformin And A Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • Hta In The Brazilian Health Care System and Potential Lessons Learned For Other Brics States

    Nov 1, 2014, 00:00

  • Access To Non Communicable Disease Medicines in India- A Comparative Analysis of State Level Public Procurement Data

    Nov 1, 2014, 00:00

  • The Expanding Role Of The Patient Voice In Medical Decision Making In Asia

    Nov 1, 2014, 00:00

  • Cost Analysis Of Pharmaceutical Service In Hospital- A Case Study In A Tertiary Hospital In Sichuan, China

    Nov 1, 2014, 00:00

  • Projection of Long Term Health-Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Type 1 Diabetes, A Uk Perspective

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Disease Management Programs For Cardiovascular Risk And Copd In The Netherlands

    Nov 1, 2014, 00:00

  • Treatment Patterns in Hyperlipidemia Patients With New Cardiovascular Events - Estimates From Population-Based Register Data in Sweden

    Nov 1, 2014, 00:00

  • Orphan Drug Policy- Approaches To Market Access In Multiple Countries

    Nov 1, 2014, 00:00

  • Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Pazopanib Verse Sunitinib as First-Line Treatment of Metastatic Renal Cell Carcinoma (MRCC) iN Spain

    Nov 1, 2014, 00:00

  • Cost Of Bleeding In Trauma Patients

    Nov 1, 2014, 00:00

  • Evaluation of Patient and Financial Outcomes Associated With Advanced Infertility Treatment Options

    Nov 1, 2014, 00:00

  • Renal Denervation With The Symplicity Catheter System For Treatment-Resistant Hypertension- A Budget Impact Analysis

    Nov 1, 2014, 00:00

  • Patient-Reported Outcomes (Pro) in Go/No-Go Decision Making in Drug Development

    Nov 1, 2014, 00:00

  • Budget Impact Evaluation Of Treatment With A Low Protein Diet And Ketoanalogues Of Essential Aminoacids For Predialysis Patients In Russian Federation

    Nov 1, 2014, 00:00

  • Value of Life and Cost of Pre-Mature Deaths With The Perspective of Productivity As Net Tax Revenue- A Comparison in France, Germany, Italy, Spain, United Kingdom

    Nov 1, 2014, 00:00

  • The Quality of Life of Patients Treated With Robotic Versus Traditional Surgery Results From An Italian Observational Multicenter Study

    Nov 1, 2014, 00:00

  • The UK Cancer Drug Fund Scoring System and the Impact of the Incremental Cost Effectiveness Ratio on Funding Decisions

    Nov 1, 2014, 00:00

  • The Burden of Severe Hypoglicaemias and Diabetes Ketoacidosis- A Population-Based Study

    Nov 1, 2014, 00:00

  • Amending the Guide to Methods of Technology Appraisal at Nice to Incorporate two New Value Elements- Burden of Illness And Wider Societal Impact

    Nov 1, 2014, 00:00

  • Assessment of Outpatient Physiotherapy Services in Diseases of the Nervous System in Hungary

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared With Cabacitaxel in Costa Rica, in Patients with Metastatic Castration-Resistant Prostate Cancer That Have Failed to Chemotherapy with Docetaxel

    Nov 1, 2014, 00:00

  • The Multicentric Castleman's Disease (Mcd) -Symptom Scale (Mcd-Ss)- Development and Validation of A Patient-Reported Outcome (Pro) Measure for An Ultra-Orphan Disease

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes On Oral Antidiabetic Drugs In Greece

    Nov 1, 2014, 00:00

  • Price Negotiation For Pharmaceuticals in Germany- High Influence Of Eu Price Weighting Method

    Nov 1, 2014, 00:00

  • The Place of Dpp-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2- A Systematic Review of Cost-Effectiveness Studies

    Nov 1, 2014, 00:00

  • Economic Burden of Childhood Injury- A Review

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Alk Rearranged Advanced Non-Small Cell Lung Cancer

    Nov 1, 2014, 00:00

  • Burden of Disease in Asian Countries and the use of Disability-Adjusted Life-Years and Quality-Adjusted Life-Years

    Nov 1, 2014, 00:00

  • Modelling the Relationship between Sustained Virologic Response and Treatment Uptake Rates on Future Prevalence and Incidence of Hepatitis C in the UK

    Nov 1, 2014, 00:00

  • COST EFFECTIVENESS ANALYSIS OF ANTIDEPRESSANTS ON BREAST CANCER PATIENTS- A MARKOV MODELING STUDY

    Nov 1, 2014, 00:00

  • The Cost of NSCLC Treatment in Three Countries- France, Germany and UK

    Nov 1, 2014, 00:00

  • Medical Costs of Cardiovascular Diseases in Taiwan

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Dapagliflozin Compared To Dpp-4 Inhibitors as Triple Therapy In Combination With Metformin and A Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • Health-Related Quality of Life for Patients with Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2014, 00:00

  • An Evaluation of Patient Satisfaction In Pafos, Cyprus With The “Europep” Instrument

    Nov 1, 2014, 00:00

  • Estimation of Stress Resistance of Medical Students in LVIV

    Nov 1, 2014, 00:00

  • Health Utility in Patients Following Cardiovascular Events

    Nov 1, 2014, 00:00

  • What Is The Patients' Median Delay From The Referring Community Health Worker To Arrival in the Link Health Facility?

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis Of Sofosbuvir For Treatment Of Genotype2 Chronic Hepatitis C In Japan

    Nov 1, 2014, 00:00

  • A Cost-Effectiveness Analysis of Different Types of Labor for Singleton Pregnancy – Real Life Data

    Nov 1, 2014, 00:00

  • Current Annual Cost Calculation is the Best Predictor of Mortality at Three Years in COPD

    Nov 1, 2014, 00:00

  • Understanding the Rationale for Responses to a Time-Trade-Off Assessment and Willingness-To-Pay in Lung Cancer in Thailand

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Emergency Hormonal Contraception With Ulipristal Acetate Versus Levonorgestrel for Minors in France

    Nov 1, 2014, 00:00

  • Maintenance Daily Dose of Venlafaxine and Duloxetine in the Monotherapy of Patients with Major Depressive Disorder Resistant to Selective-Serotonin-Reuptake-Inhibitors in Routine Clinical Practice in Spain

    Nov 1, 2014, 00:00

  • A Literature Review on Cost-Effectiveness of Treatments for Wet Age-Related Maculare Degeneration

    Nov 1, 2014, 00:00

  • Process Mapping to Capture Breast Cancer Patients' Journey in Greek Public Oncological Hospitals

    Nov 1, 2014, 00:00

  • Prevalence of Cystic Fibrosis Among the U. S. National Medicaid Population

    Nov 1, 2014, 00:00

  • Body Mass Index (BMI) as A Predictor of Outcome After Coronary Artery Bypass Grafting- An Asian Perspective

    Nov 1, 2014, 00:00

  • Comparative Effectiveness in Terms of Treatment Discontinuation of Orodispersable Versus. Standard Oral Olanzapine Tablets in Non-Adherent Patients- Results from a 1-Year European Outpatient Observational Study

    Nov 1, 2014, 00:00

  • Treatment Patterns And Quality Of Life Of Patients With Non-Valvular Atrial Fibrillation- An Experience Of A Tertiary Health Care Centers (Treq-Af Study)

    Nov 1, 2014, 00:00

  • Assessing Heterogeneity of Treatment Effect Using Real World Data

    Nov 1, 2014, 00:00

  • Transferability of Economic Evaluations To Central and Eastern Euroepan and Former Soviet Countries

    Nov 1, 2014, 00:00

  • Analysis of Cost-Effectiveness Assessments In France By The French National Authority For Health (Has)

    Nov 1, 2014, 00:00

  • Doctors' Failure in Observance of the COPD Management Guidelines- Case of the CZECH Republic

    Nov 1, 2014, 00:00

  • Cost Analysis of the Use of Glatiramer Acetate Compared to Interferon-Â in Patients with Relapsing-Remitting Multiple Sclerosis and Spasticity in Spain

    Nov 1, 2014, 00:00

  • Generating Health State Utility Values from Fact-Ovarian Data Collected in a Phase Ii Maintenance Study in Platinum Sensitive Recurrent Ovarian Cancer (Study 19)- A Comparison of Mapping Algorithms

    Nov 1, 2014, 00:00

  • Implications Of External Price Referencing of Pharmaceuticals in Middle East Countries

    Nov 1, 2014, 00:00

  • Effect of Smoking Status on Health Care Costs In Patients With Type 2 Diabetes- A Retrospective Nested Case-Control Economic Study In Routine Clinical Practice

    Nov 1, 2014, 00:00

  • The Impact on Drug Price and Patiet Selection of National Essential Drug System- Evidence From Inpatient Records from Insurance Reimbursement Data

    Nov 1, 2014, 00:00

  • Can A Cvd Polypill Save Money In The ‘Real World'?

    Nov 1, 2014, 00:00

  • Pain Incidence and Analgesic Consumption During Haemodialysis Sessions- Impact on Health-Related Quality Of Life

    Nov 1, 2014, 00:00

  • Resource Utilization Pattern And Cost Of Tuberculosis Treatment In Penang, Malaysia

    Nov 1, 2014, 00:00

  • Acute Ischemic Stroke (Ais) Patient Management in French Stroke Units and Impact Estimation of Thrombolysis On Care Pathways and Associated Costs

    Nov 1, 2014, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108 (current)
  • 109
  • 110
  • »